Young Il Kim

Young Il Kim

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2019 in British Journal of Surgery
Verified
Journal Article
Closed access
PDF file
YKYoung Il Kim
Young Il Kim
Song Cheol KimSong Cheol Kim
Song Cheol Kim
YLY.‐J. Lee
Y.‐J. Lee
KPK.‐M. Park
K.‐M. Park
DHD. W. Hwang
D. W. Hwang
Song Cheol KimSong Cheol Kim
Song Cheol Kim

6 May 2021 in Cancers
Verified
Journal Article
Open access
PDF file
JCJu Yeon Choi
Ju Yeon Choi
IPIn Ja Park
In Ja Park
HLHyun Gu Lee
Hyun Gu Lee
ECEunhae Cho
Eunhae Cho
YKYoung Il Kim
Young Il Kim
CKChan-wook Kim
Chan-wook Kim
Because of their reluctance to visit the hospital due to concerns about contracting coronavirus disease 2019 (COVID-19), patients with colorectal cancer have been affected by delays in care during the pandemic. This study assessed the effects of the pandemic on the clinical characteristics and surgical treatment patterns of colorectal cancer patients at a tertiary medical facility in Korea. Patients who underwent colorectal cancer surgery at our institution between March and September 2020 were analyzed. Clinicopathological and treatment characteristics were compared with those of patients who underwent surgery in 2018 and 2019. The patients who did not undergo tumor resection (4.1% vs. 1.8%, p < 0.001) and who received neoadjuvant treatment (16.7% vs. 14.7%, p = 0.039) were significantly higher during the COVID period. The minimally invasive approach was performed less during the COVID period (81.2% vs. 88%, p < 0.001). More patients in the COVID period required combined resection of organs adjacent to the tumor (4.8% vs. 2.8%, p = 0.017). Surgical aggressiveness, as shown by the proportion of patients undergoing minimally invasive surgery and adjacent organ resection, was significantly influenced by the pandemic. In addition, resectability decreased during the COVID period. These characteristics will likely influence long-term oncological outcomes, indicating the need for long-term monitoring of this cohort.

10 September 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HSHeeji Shin
Heeji Shin
KSKi Byung Song
Ki Byung Song
YKYoung Il Kim
Young Il Kim
YLYoung-Joo Lee
Young-Joo Lee
DHDae Wook Hwang
Dae Wook Hwang
Song Cheol KimSong Cheol Kim
Song Cheol Kim
There is little evidence on the safety and benefits of laparoscopic pancreaticoduodenectomy (LPD) in elderly patients; therefore, we evaluated the feasibility and efficacy of this procedure by comparing perioperative and oncological outcomes between LPD and open pancreaticoduodenectomy (OPD) in elderly patients. We retrospectively reviewed the data of 1,693 patients who underwent PD to manage periampullary tumours at a single institution between January 2014 and June 2017. Of these patients, 326 were elderly patients aged ≥70 years, with 56 patients allocated to the LPD group and 270 to the OPD group. One-to-one propensity score matching (56:56) was used to match the baseline characteristics of patients who underwent LPD and OPD. LPD was associated with significantly fewer clinically significant postoperative pancreatic fistulas (7.1% vs. 21.4%), fewer analgesic injections (10 vs. 15.6 times; p = 0.022), and longer operative time (321.8 vs. 268.5 minutes; p = 0.001) than OPD in elderly patients. There were no significant differences in 3-year overall and disease-free survival rates between the LPD and OPD groups. LPD had acceptable perioperative and oncological outcomes compared with OPD in elderly patients. LPD is a reliable treatment option for elderly patients with periampullary tumours.

1 January 2020 in Annals of Surgical Treatment and Research
Verified
Journal Article
Open access
YKYoung Il Kim
Young Il Kim
IPIn Ja Park
In Ja Park
JPJin-Hong Park
Jin-Hong Park
TKTae Won Kim
Tae Won Kim
JRJun-Soo Ro
Jun-Soo Ro
JKJin Cheon Kim
Jin Cheon Kim
The rare incidence of isolated para-aortic lymph node (PALN) recurrence of colorectal cancer has precluded the formulation of treatment guidelines. This study evaluated and compared the effects of different treatment modalities on survival outcomes in patients with PALN recurrence. Patients diagnosed with isolated PALN recurrence after curative resection for primary colorectal cancer from January 2004 to December 2014 were evaluated retrospectively. Patients with isolated recurrence were selected using imaging modalities. Overall survival (OS) and survival after recurrence (SAR) were analyzed and compared between different treatments using the Kaplan-Meier method. The median OS was 64 months with a median follow-up time of 50 months. Of the 46 patients with PALN recurrence, 35 (76.1%) had isolated recurrences. Of these 35 patients, 16 underwent PALN resection and 19 received chemotherapy. Median SAR was significantly longer in patients who did than did not undergo resection (71 months vs. 39 months, P = 0.017). Median OS tended to be longer in patients who did than did not undergo resection (77 months vs. 62 months, P = 0.055). SAR was similar in patients who received radiotherapy and those who underwent resection (34 months vs. 46 months, P = 0.146). Three of 16 patients (18.8%) who underwent resection were found to be recurrence-free. Surgical resection of isolated PALN recurrence may benefit patients, with favorable survival outcomes and by providing definitive diagnosis for proper treatment planning.

11 October 2023 in Journal of Robotic Surgery
Verified
Journal Article
Closed access
PDF file
JJJin-Min Jung
Jin-Min Jung
YKYoung Il Kim
Young Il Kim
YYYong Sik Yoon
Yong Sik Yoon
SYSongsoo Yang
Songsoo Yang
MKMin Hyun Kim
Min Hyun Kim
CYChang Sik Yu
Chang Sik Yu

1 January 2015 in Korean Journal of Hepato-Biliary-Pancreatic Surgery
Verified
Journal Article
Open access
PDF file
YKYoung Il Kim
Young Il Kim
SSSang Hyun Shin
Sang Hyun Shin
KSKi Byung Song
Ki Byung Song
DHDae Wook Hwang
Dae Wook Hwang
JLJae Hoon Lee
Jae Hoon Lee
Song Cheol KimSong Cheol Kim
Song Cheol Kim
International treatment guidelines for branch duct intraductal papillary mucinous neoplasm (BD-IPMN) of the pancreas have been proposed, for features associated with malignancy and invasiveness. We investigated the clinicopathological characteristics that are predictive of malignancy or invasiveness and disease recurrence. A review of 324 patients with resected and pathologically confirmed BD-IPMN, between March 1997 and December 2013, was conducted. There were 144 (44.4%) low grade dysplasia (LGD), 138 (42.6%) intermediate grade dysplasia (IMGD), 17 (5.3%) high grade dysplasia (HGD), and 25 (7.7%) invasive carcinoma (invIPMC) cases. The 5-year survival rates were 98.1% for LGD, 95.3% for IMGD, 100% for HGD, and 71.8% for invIPMC. Through a univariate analysis, the male sex was associated with malignancy, and CA19-9 was related to both malignant and invasive IPMN. The high risk or worrisome features of the international guidelines were associated with both malignant and invasive IPMN: the total bilirubin of the head/uncinate lesion, tumor size, mural nodule, and the size of the main pancreatic duct (MPD). Through a multivariate analysis, the male sex, elevated CA19-9, mural nodule, and dilated MPD diameter were independently correlated with the malignant IPMN. The elevated CA19-9 and dilated MPD diameter were also correlated with invasive carcinoma. The patient age and the initial pathological diagnosis were strongly associated with disease recurrence following surgical resection. The high risk or worrisome features in the current treatment guidelines for BD-IPMN are confined to the morphological characteristics of the disease. Patient factors and biological features should also be considered in order to develop optimal therapeutic or surveillance strategies.